APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 73 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $685 | -71.6% | 7,521 | -79.5% | 0.00% | -25.0% |
| Q1 2023 | $2,412 | +349.2% | 36,600 | +251.9% | 0.00% | +100.0% |
| Q4 2022 | $537 | -99.9% | 10,400 | -19.4% | 0.00% | -50.0% |
| Q3 2022 | $881,000 | +111.8% | 12,900 | +40.2% | 0.00% | +100.0% |
| Q2 2022 | $416,000 | +156.8% | 9,200 | +187.5% | 0.00% | +100.0% |
| Q1 2022 | $162,000 | +11.0% | 3,200 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $146,000 | -81.8% | 3,100 | -87.2% | 0.00% | -66.7% |
| Q3 2021 | $800,000 | -20.9% | 24,300 | +51.9% | 0.00% | -25.0% |
| Q2 2021 | $1,011,000 | +421.1% | 16,000 | +370.6% | 0.00% | +300.0% |
| Q4 2020 | $194,000 | -39.4% | 3,400 | -65.3% | 0.00% | 0.0% |
| Q2 2020 | $320,000 | -61.6% | 9,800 | -68.5% | 0.00% | -75.0% |
| Q1 2020 | $833,000 | -12.5% | 31,100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $952,000 | -41.5% | 31,100 | -54.0% | 0.00% | 0.0% |
| Q3 2019 | $1,628,000 | +2294.1% | 67,600 | +2080.6% | 0.00% | – |
| Q1 2018 | $68,000 | +1.5% | 3,100 | 0.0% | 0.00% | – |
| Q4 2017 | $67,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |